Metronidazole
(Synonyms: 甲硝唑) 目录号 : GC15775An antibiotic
Cas No.:443-48-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Metronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa.Target: Antibacterial; AntiparasiticMetronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa. Metronidazole is an antibiotic, amebicide, and antiprotozoal.[1] It is the drug of choice for first episodes of mild-to-moderate Clostridium difficile infection [2]. Metronidazole, taken up by diffusion, is selectively absorbed by anaerobic bacteria and sensitive protozoa. Once taken up by anaerobes, it is non-enzymatically reduced by reacting with reduced ferredoxin, which is generated by pyruvate oxido-reductase. Many of the reduced nitroso intermediates will form sulfinamides and thioether linkages with cysteine-bearing enzymes, thereby deactivating these critical enzymes. As many as 150 separate enzymes are affected.In addition or alternatively, the metronidazole metabolites are taken up into bacterial DNA, and form unstable molecules. This function only occurs when metronidazole is partially reduced, and because this reduction usually happens only in anaerobic cells, it has relatively little effect upon human cells or aerobic bacteria.[3]
甲硝唑是一种硝基咪唑类抗生素药物,特别用于厌氧菌和原虫感染。甲硝唑是一种抗生素,阿米巴杀虫药和抗原虫药[1]。它是轻度至中度难治性难辨谔菌感染首选药物[2]。甲硝唑通过扩散被细菌和敏感原虫选择性吸收。一旦被厌氧菌吸收,它将与还原型三硫化铁蛋白发生非酶反应被非酶还原,生成的许多还原型亚硝基中间体将形成磺酰胺和半乙硫醚与半胱氨酸酶结合,从而使这些关键酶失活。最多可影响150种不同的酶。此外或替代的是,甲硝唑代谢物被细菌DNA吸收,形成不稳定分子。只有当甲硝唑部分还原时才会发生这种功能,因为这种还原通常仅发生在厌氧细胞中,所以对人体细胞或好氧细菌的影响相对较小[3]。
References:
[1]. In Schaechter, M.; Engleberg, N. C.; DiRita, V. J. et al. Schaechter's Mechanisms of Microbial Disease. Hagerstown, MD: Lippincott Williams & Wilkins. p. 28.
[2]. http://www.drugs.com/monograph/metronidazole.html
[3]. Cohen, S.H., et al., Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol, 2010. 31(5): p. 431-55.
Cas No. | 443-48-1 | SDF | |
别名 | 甲硝唑 | ||
化学名 | 2-(2-methyl-5-nitroimidazol-1-yl)ethanol | ||
Canonical SMILES | CC1=NC=C(N1CCO)[N+](=O)[O-] | ||
分子式 | C6H9N3O3 | 分子量 | 171.15 |
溶解度 | DMF: 15 mg/ml,DMSO: 15 mg/ml,Ethanol: 5 mg/ml,PBS (pH 7.2): 2 mg/ml | 储存条件 | 4°C, protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 5.8428 mL | 29.2141 mL | 58.4283 mL |
5 mM | 1.1686 mL | 5.8428 mL | 11.6857 mL |
10 mM | 0.5843 mL | 2.9214 mL | 5.8428 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。